Inventor

DE LACHARRIERE OLIVIER

FR47 patents

⚠️ This page may combine multiple inventors who share the name “DE LACHARRIERE OLIVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DE LACHARRIERE OLIVIER

OREAL

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin

Topical composition containing a substance P antagoinst

Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same

Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discreet erythema

Topical composition containing capsazepine

Cosmetic/dermatological skin care compositions comprising S-DHEA

Topical composition containing a substance P antagonist

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema

Compositions and methods for treating wrinkles and/or fine lines of the skin

Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it

Iridaceae extract and compositions containing it

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids

Alkaline-earth metal salt for the treatment of ocular or palpebral pruritus and dysesthesia

Compositions and methods for treating wrinkles and/or fine lines of the skin

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin

Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same

Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists

Antiperspirant compositions comprising substance P antagonists

Substance P antagonist for the treatment of lichens, prurigo, pruritus

Modulating body/cranial hair growth

Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists

Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained

Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained

Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins

Methods involving artificial intelligence

Topical composition containing capsazepine

Therapeutic/cosmetic compositions comprising bradykinin antagonists for treating sensitive human skin

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids

Use of a substance P antagonist for the treatment of skin reddening of neurogenic origin

Ethylenediamine derivative in a cosmetic or dermatological composition, and composition containing in particular a product having an irritant side effect

Use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF αantagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained

Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists

Permanent wave compositions comprising substance P/CGRP antagonists

Use of a composition containing an effective quantity of at least one ion chelating agent for increasing the tolerance threshold of a sensitive or intolerant skin

Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent

SOCIETEL OREAL S A

Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained

Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists

Cosmetic/dermatological skin care compositions comprising S-DHEA

Composition for dyeing keratin fibres containing a substance P antagonist

Use of at least one thermal spring water from Vichy as a substance P antagonist

DE LACHARRIERE OLIVIER

Use of active principles which are capable of enhancing the content of ceramides, as protective agent for delicate lips

Non-therapeutic methods of evaluating skin neurosensitivity, kit and use of a kit for implementing the method

SOCIETE L'OREAL SA

Use of a substance P antagonist for the treatment of pruritus, ocular and/or palpebral pain and ocular or palpebral dysaesthesia

SOCI ET E L OR EAL S A

Therapeutic/cosmetic compositions comprising bradykinin antagonist for treating sensitive human skin

L OREAL SOC

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin

BERNARD BRUNO

Uses of BNIPXL-beta in premature canities